PTEN and cancer: Since the early discovery of oncogenes (e.g., MYC, RAS, BRAF and KIT) and tumor suppressor genes (e.g., TP53, BRCA1 and PTEN), cancer-associated genetic lesions have been extensively documented [9,10].